Epirium Bio is a clinical-stage biopharmaceutical company developing therapeutics that promote mitochondrial biogenesis and function through a novel mechanism of action discovered by the company.
Location: Canada
Employees: 11-50
Total raised: $85M
Founded date: 2008
Investors 5
| Date | Name | Website |
| - | The Longev... | longevity.... |
| 17.07.2021 | ARCH Ventu... | archventur... |
| - | BlueBird V... | bluebirdvc... |
| - | Adams Stre... | adamsstree... |
| - | Longitude ... | longitudec... |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 22.12.2019 | Series A | $85M | - | vcnewsdail... |
Mentions in press and media 5
| Date | Title | Description | Source |
| 23.09.2020 | Healthcare VC Firm Longitude Capital Closes $585M Fund | What You Should Know: – Healthcare venture capital firm Longitude Capital announces the close of it... | hitconsult... |
| 23.09.2020 | Longitude Capital Raises $585 Million Fund to Invest in Tran... | - Longitude Venture Partners IV will build on the Firm’s commitment to improve clinical outcomes, en... | marketscre... |
| 22.12.2019 | Epirium Raises $85 Million to Treat Muscle Diseases | Epirium surfaced Dec... Take 1 minute to subscribe and you'll get this story immediately, plus: Al... | sdbj.com/n... |
| 19.12.2019 | Epirium Raises $85M in Hopes of Treating Muscle Diseases | - | connect.or... |
| 19.12.2019 | Epirium Bio Scores $85M Series A | SAN FRANCISCO, CA, Epirium Bio today announced it has raised $85 million in Series A financing. &... | vcnewsdail... |